Who is sponsoring DexmedMRI?

DexmedMRI is sponsored by University of British Columbia.

What condition does DexmedMRI study?

DexmedMRI studies MRI Sedation.

What drugs are being tested in DexmedMRI?

Interventions: Dexmedetomidine.

What is the status of DexmedMRI?

DexmedMRI is currently UNKNOWN.

Last reviewed 2019-01-23 · How we verify

Intra-nasal Dexmedetomidine for Children Undergoing MRI Imaging (DexmedMRI)

NCT03806777 Phase 4 UNKNOWN

This study aims to assess the use of intranasal dexmedetomidine (IN-dex) as a sole agent in aiding the successful completion of a MRI scans in children. Dexmedetomidine, a routinely used anesthetic agent in our institution, has many benefits including sedation with neuro-protective and respiratory sparing features. We will test its effectiveness in completing MRI scans in children that would otherwise be given a full general anesthetic.

Details

Lead sponsor	University of British Columbia
Phase	Phase 4
Status	UNKNOWN
Enrolment	180
Start date	2019-02
Completion	2020-10

Conditions

MRI Sedation

Interventions

Dexmedetomidine

Primary outcomes

Dose — Immediately after completion of the MRI scan.
The intranasal dexmedetomidine dose in mcg/kg that produces successful completion of MRI scan with acceptable MRI image quality in 90% of individuals (ED 90).